STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

United States Antimony SEC Filings

UAMY NYSE

Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Antimony tonnage tables, reclamation liabilities, fluctuating smelter yields—United States Antimony’s SEC documents can overwhelm even experienced analysts. Whether you are searching for “United States Antimony SEC filings explained simply” or need the latest “United States Antimony insider trading Form 4 transactions”, the raw EDGAR feed alone rarely answers core valuation questions.

Stock Titan solves this problem with an AI layer built for complex resource companies. Our system scans every 10-K, 10-Q, 8-K and proxy in real time, then delivers plain-English summaries alongside the original text. You’ll see environmental footnotes, mine-life assumptions and segment revenue called out automatically. Need to monitor Form 4 activity? We provide “United States Antimony Form 4 insider transactions real-time” alerts so you learn when executives buy or sell before the market digests the move. Looking for production trends? Our dashboards link the “United States Antimony quarterly earnings report 10-Q filing” to historical ore grades and cash-cost metrics.

Here’s what becomes effortless:

  • Compare year-over-year mine output using data extracted from the annual report 10-K simplified
  • Track executive stock transactions Form 4 against antimony price swings
  • Review proxy statement executive compensation details next to production bonuses
  • Decode 8-K material events explained—from furnace shutdowns to offtake agreements

With comprehensive coverage and instant AI commentary, Stock Titan turns hundreds of pages into decisive insight. Stop skimming PDFs and start understanding United States Antimony SEC documents with AI in minutes.

Rhea-AI Summary

United States Antimony Corporation commenced an at-the-market offering of up to $400,000,000 of common stock, to be sold from time to time through A.G.P./Alliance Global Partners and B. Riley Securities as agents or principals. Sales may be made pursuant to Rule 415(a)(4) with no minimum amount required.

The company will pay the Agents up to 3.0% of the gross sales price per share and plans to use any net proceeds to acquire antimony and other critical mineral inventory, expand leasehold positions in Alaska and Montana, pursue acquisitions, potentially increase capacity at the Madero Smelter in Mexico, and for general working capital.

As context, the last reported sale price was $16.71 per share on October 13, 2025, and shares outstanding were 138,878,411 as of that date. The filing illustrates potential dilution: at an assumed price of $16.71, pro forma as adjusted net tangible book value would be $3.24 per share, implying $13.47 per-share dilution to new investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.91%
Tags
prospectus
-
Rhea-AI Summary

United States Antimony Corporation entered a Securities Purchase Agreement for a registered direct offering of 2,377,657 shares of common stock at $10.50 per share, for approximately $25 million in gross proceeds. The company expects net proceeds of $24,431,090.53 after the placement commission and a credit, with closing expected on or about October 14, 2025, subject to customary conditions.

The deal is being made off the company’s effective Form S-3 shelf and a Rule 462(b) S-3MEF. Titan Partners Group acted as exclusive placement agent with a 7% commission, subject to a credit. Separately, the company reduced its ATM capacity from $65,000,000 to $39,885,000 effective October 6, 2025, and as of October 10, 2025, cannot sell under the existing ATM prospectus supplement unless and until new offering documents are filed; the sales agreement remains in force.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.22%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.22%
Tags
prospectus
Rhea-AI Summary

John M. Keane, a director of United States Antimony Corp (UAMY), filed an Initial Statement of Beneficial Ownership reporting no currently owned common shares and two time‑based awards granted on 08/19/2025. The filing shows 68,200 restricted stock units (RSUs) and a stock option covering 34,100 shares, each vesting one‑third on 08/19/2026, 08/19/2027, and 08/19/2028$4.26 and an expiration date of 08/19/2035. The RSUs convert to common stock at vesting; no direct common shares were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.39%
Tags
current report
-
Rhea-AI Summary

United States Antimony Corp (UAMY) director and officer Lloyd Bardswich reported a sale of 40,000 shares of the company's common stock on 09/29/2025 at a price of $6.44 per share. After the sale the filing shows beneficial ownership listed as 594.047 (as reported). The Form 4 was signed by the reporting person on 10/04/2025. No derivative transactions or additional purchases were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.39%
Tags
insider
-
Rhea-AI Summary

Jeffrey Russell Fink, an officer and director of United States Antimony Corp (UAMY), reported two open-market dispositions on 10/03/2025. The filing shows a sale of 2,833 shares at $8.16 and a sale of 8,000 shares at $8.12. After those transactions the reported beneficial ownership totals are listed as 64,000 shares and 56,000, respectively, held in a direct capacity. The Form 4 is signed by the reporting person and indicates the transactions were not reported as part of a 10b5-1 plan. The filing provides a straightforward record of insider selling activity without additional commentary or explanatory notes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UAMY filed a Form 144 notice for proposed sales of common stock.

The notice lists 2,833 shares (aggregate market value $23,103.12) and 8,000 shares (aggregate market value $64,960.80) to be sold through Merrill Edge on NYSE American, with an approximate sale date of October 3, 2025. The seller acquired 33,333 shares via restricted stock vesting on January 29, 2025 as compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of United States Antimony (UAMY)?

The current stock price of United States Antimony (UAMY) is $5.79 as of November 25, 2025.

What is the market cap of United States Antimony (UAMY)?

The market cap of United States Antimony (UAMY) is approximately 823.4M.
United States Antimony

NYSE:UAMY

UAMY Rankings

UAMY Stock Data

823.41M
121.17M
16.63%
26.61%
12.95%
Other Industrial Metals & Mining
Primary Smelting & Refining of Nonferrous Metals
Link
United States
DALLAS